Hi Hylander. Im not sure if you mean me as one, but I

New Post Public Reply Private Reply Replies (3) Message Board
rjs9787 hylander #35585
734
Hi Hylander. Im not sure if you mean me as one, but I wasn’t the mentally clearest the previous two months. Like the neurologist said Friday, I’m a bit miraculous how I’m functionally walking and talking. He expected that in another six months.

I don’t see any possible future for Generex or NuGenerex unless somehow Dr. Eric von Hofe, Jason Terrell, Rich Purcell or any actually smart in biotechnology/life sciences takes over WITH NO ASSOCIATION WITH JOE MOSCATO. I embarrassingly supported him, although former DigitalTradz members will recall I harshly debated him over awful acquisition attempts and even banned him for awhile. Joe got lucky GNBT had support. He earned none of it. He benefited from us all organized at DigitalTradz.

DigitalTradz himself did a lot, but would be logged off a good year before a couple posts. You, me etc gave GNBT their following. Weekly kickoffs for a decade where I’d sit at the Jersey shore on a Sunday asking what can even be said? Joe had ZERO part in creating or embracing the support we simply HANDED to him.

Ridiculous. He’s always in lawsuits galore. He never can point to a success. Mussel Pot failed and ended the in the awful fowl mouthed charges against one another. Nothing respectable- ever. Im embarrassed by that. I thought his “edge” could help our quiet company. Instead, he is by far the worst CEO ever in biotech or in Generex. Anna was far better l. She acquired Antigen Express, had a handful or two studies and peer reviews. Joe has never had ONE peer review. He just loud mouth talked about one that never came.

The only one that hid like a child and abandoned shareholders is Joe Moscato. He’s afraid to respond to any of our inquiries. He babbles foolishly on Facebook about him being right about mRNA vaccines. He gets a like or 3. Jeez, i make a post and it has over 200 comments. Joe has ZERO following.

And personally, I feel terrible for trying to always cleam him up, delete his embarrassing low IQ posts when he attacks shareholders. Todd Falls does nothing. He should try saving Generex from an unsophisticated Joe on these forums since 2010. And now Joe has blocked me from all his social media. No tearful excuse. Not even a BS attempt at an explanation over his pathetic failure. Just hiding, block, like a weasel. Pathetic man.

My slowdown in posts? I would post a few days after two brain surgeries that I feel great lol. Then I learned that doesn’t last long. I think im good the last few days. Neurosurgeon said I can finally lift over 20 pounds, start driving in a couple weeks slowly (no bridges yet), and i run my biz still by just spreading responsibilities around.

Joe- are you ever responsible? It appears that you always fail.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MCatalysis Secures $5M to Disrupt Fuel Cost Dynamics

Updated Category News Views 3

Funding Fuels Innovation MCatalysis has just secured a hefty $5 million in seed funding to throw down with the big dogs in energy production. This isn't your regular backyard science project; this company is serious about changing the game with a tech-driven approach that could undercut current fuel prices. HL Energy Ventures and Oxford Science Enterprises are backing...

Continue Reading
Job Market Shifts: Adaptation vs. Fairness Dilemma

Updated Category News Views 3

The Chameleon Effect in Today's Job Market Walk into any open-space office these days, and you'll see faces plastered with composed, work-ready smiles—faces that might not look so familiar outside those walls. The modern workplace has draped its cloak over individual personalities, with the mighty pressure to 'fit in' often forcing a change in how folks present...

Continue Reading
Health Net's $2M Boost for Stanislaus Affordable Housing

Updated Category News Views 3

Joining the Fight Against California’s Housing Crisis Well, I'll be the first to say it's a breath of fresh air when a healthcare beast like Health Net starts investing in something as critical as affordable housing. This is no drop in the bucket—two million dollars is quite the commitment to fix some of the mess that’s been brewing in Stanislaus County, California....

Continue Reading
CUBEX Lights Up Veterinary Care with Mini Essential

Updated Category News Views 5

Inventory Woes? Meet Mini Essential If you’ve ever worked in or around veterinary hospitals, you know the old-school headaches of managing controlled substances. Picture this: piles of paper logs, end-of-shift recounting, and inevitable discrepancies that rear their ugly heads long after closing time. Enter CUBEX, shaking things up with their latest launch, Mini...

Continue Reading
Cap Juluca: Caribbean Luxury Redefined on Maundays Bay

Updated Category News Views 2

The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...

Continue Reading
Sandbox VR Expands to Melbourne, Betting on Immersive Fun

Updated Category News Views 3

Sandbox VR Ventures into Melbourne's Heart Every now and then, a venture takes its ambitions and rolls the dice on a prime location. Sandbox VR is swaggering into Melbourne's bustling Central Business District, fresh out of its success on the Gold Coast. Opening this Melbourne venue on September 14 marks a significant leap in the company's Aussie expansion—a bold nod to...

Continue Reading
Shareholder Rights in Focus: Examining Key Buyouts

Updated Category News Views 4

Shareholder Concerns Rise Amid Corporate Buyouts The stakes are high for the shareholders of Distribution Solutions Group, Eagle Financial Services, Safety Insurance Group, and Utz Brands as their companies face potential buyouts. Let's chew over what's on the table: the sweet deals insiders might score and the legal maneuvers in play. Halper Sadeh LLC, a heavy-hitting...

Continue Reading
Veho's Role in Redefining Beauty E-Commerce Delivery

Updated Category News Views 2

Veho Grabs Headlines with BeautyMatter Awards Nod Here's something a bit off the beaten path: Veho's been tapping into new wells of opportunity in the e-commerce sector, and their latest accolade demonstrates just that. Named a finalist in the 2026 BeautyMatter Awards under the Logistics category, they're making noise in all the right circles. Beyond Boxes: Transforming...

Continue Reading
Push Notification Security Transforms Healthcare IT Support

Updated Category News Views 2

Cutting the Fat on IT Help Desk Bottlenecks Healthcare IT teams are fighting an uphill battle with password resets, a mundane task consuming up to half of all help desk calls. It's like trying to stop a leaking dam with duct tape. For health systems, these calls aren't just a minor annoyance—they're a full-fledged budget hog. Try telling a CIO that an agent-friendly...

Continue Reading
Aflac's $200M Milestone in Cancer Charity Support

Updated Category News Views 3

Pioneering Efforts Across Decades Here’s an effort that bucks the usual corporate talk. Aflac, the supplemental insurance giant, isn’t just mumbling about its mission; it's doing the heavy lifting in the fight against childhood cancer and blood disorders. With over $200 million in contributions poured into the cause over more than 30 years, they're putting the capital...

Continue Reading

Top 5 Most Recently Viewed Articles

Alkermes Unveils 8th Year of Pathways Research Awards Program

Updated Category News Views 125

Alkermes Launches 8th Annual Pathways Research Awards Program Alkermes plc (NASDAQ: ALKS) recently announced the commencement of its competitive grant program aimed at fostering innovative research in neuroscience. The Alkermes Pathways Research Awards program is set to offer individual grants of up to $100,000 for projects focused on significant issues in mental health....

Continue Reading
Griffith Foundation Strengthens Advisory Council with New Members

Updated Category News Views 250

Griffith Foundation Strengthens Advisory Council The Institutes Griffith Foundation unveils the newest members of its Advisory Council, welcoming R. Dale Hall and Lorilee Medders. These appointments mark a significant milestone for the organization as it seeks to enhance its educational offerings and outreach. Meet the New Members R. Dale Hall's Background R. Dale Hall is...

Continue Reading
ReShape Lifesciences Partners with Recon Supply for Veteran Care

Updated Category News Views 153

New Collaboration to Enhance Veteran Healthcare ReShape Lifesciences® (Nasdaq: RSLS), a leading company in weight loss and metabolic health solutions, has formed an exclusive distribution agreement with Recon Supply to significantly improve healthcare access for veterans and active military personnel. This strategic move aims to distribute innovative medical technologies...

Continue Reading
Exploring the Charm of the Chicken Road Game Experience

Updated Category News Views 144

Catch the Fun of Chicken Road Game In recent years, the mobile gaming industry in India has experienced remarkable growth, embracing a plethora of engaging options designed for varied preferences. Among these, one standout in the hyper-casual genre is Chicken Road, a game that has taken mobile gamers by storm. Its simplistic yet addictive structure effortlessly resonates...

Continue Reading
Investors Urged to Act in KinderCare Class Action Case

Updated Category News Views 233

Important Investor Information on KinderCare Learning Kahn Swick & Foti, LLC (KSF) is reaching out to investors who have incurred significant losses in KinderCare Learning Companies, Inc. (NYSE: KLC). If your losses exceed $100,000 and you purchased shares linked to the company's initial public offering in October 2024, it’s crucial to take note of the class action...

Continue Reading